PolarityTE Inc. (PTE) Stock

DelistedNasdaq: PTEPolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States.

0.07
Final close · Aug 16, 2023

PTE is no longer traded. PolarityTE was delisted from the Nasdaq in August 2023.

Prices on this page are historical; the last trade was August 16, 2023 at $0.07.

PolarityTE stock price history

Split-adjusted closes, 1999–2023

PTE final trading statistics

Final close
$0.07
Final trading day
Aug 16, 2023
Market cap at delisting
$1.78M
Shares outstanding
7.38M
Final 52-week range
$0.06 – $1.42
Avg. volume (final 3 mo.)
424,206
All-time high (split-adj.)
$35001.83 · May 2004
All-time low (split-adj.)
$0.06 · Jun 2023
Return since IPO
-100.0%
Beta
1.15
Book value / share
$1.74
Price / book
0.04
Final 52 wk
0.061.42

PolarityTE earnings per share

Earnings per share

PolarityTE revenue & net income

RevenueNet income

PolarityTE annual financials

PolarityTE Inc. revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$814.0K$10.2M-$4.08
FY2021$9.40M-$28.2M-$8.00
FY2020$10.13M-$43.9M-$32.50
FY2019$5.65M-$92.3M-$93.25
FY2018$1.56M-$65.4M-$67.75

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About PolarityTE Inc.

PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

PolarityTE stock FAQ

What happened to PolarityTE stock?

PolarityTE stock was delisted from the Nasdaq. Its final close was $0.07 on August 16, 2023.

Is PTE stock still trading?

No. PTE was delisted from the Nasdaq in August 2023 and no longer trades on a U.S. exchange.

What was the last price of PTE stock?

PTE closed at $0.07 on its final trading day, August 16, 2023, for a market value of about $1.78M.

What were PolarityTE's revenue and earnings in its last full fiscal year?

PolarityTE reported revenue of $814.0K and net income of $10.2M in fiscal 2022, its last full year as a public company.

When did PolarityTE go public?

PolarityTE Inc. stock began trading on August 13, 1999.

Biotechnology & Medical Research stocks to research

All Healthcare stocks →